PE20110582A1 - Arilciclohexileteres de dihidro-tetraazabenzoazuleno - Google Patents

Arilciclohexileteres de dihidro-tetraazabenzoazuleno

Info

Publication number
PE20110582A1
PE20110582A1 PE2011001019A PE2011001019A PE20110582A1 PE 20110582 A1 PE20110582 A1 PE 20110582A1 PE 2011001019 A PE2011001019 A PE 2011001019A PE 2011001019 A PE2011001019 A PE 2011001019A PE 20110582 A1 PE20110582 A1 PE 20110582A1
Authority
PE
Peru
Prior art keywords
tetraaza
trans
benzoazulene
phenoxy
dihydro
Prior art date
Application number
PE2011001019A
Other languages
English (en)
Inventor
Patrick Schnider
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20110582A1 publication Critical patent/PE20110582A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

REFERIDA A UN DERIVADO TETRAAZABENZOAZULENO DE FORMULA (I), DONDE R1 ES UN ARILO O HETEROARILO TAL COMO FENILO, NAFTILO, PIRAZINILO, PIRIDAZINILO, PIRIDINILO O PIRIMIDINILO; R2 ES H, ALQUILO C1-C12, C(O)-ALQUILO C1-C12, ENTRE OTROS; R3 ES Cl O F. SON COMPUESTOS PREFERIDOS: TRANS-8-CLORO-1-(4-FENOXI-CICLOHEXIL)-4H,6H-2,3,5,10b-TETRAAZA-BENZOAZULENO-5-CARBOXILATO DE TERT-BUTILO, CLORHIDRATO DE TRANS-8-CLORO-1-(4-FENOXI-CICLOHEXIL)-5,6-DIHIDRO-4H-2,3,5,10b-TETRAAZA-BENZOAZULENO, TRANS-8-CLORO-5-METIL-1-(4-FENOXI-CICLOHEXIL)-5,6-DIHIDRO-4H-2,3,5,10b-TETRAAZA-BENZO[e]AZULENO, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD ANTAGONISTA DEL RECEPTOR DE LA V1a Y SON UTILES EN EL TRATAMIENTO DE DISMENORREA, DISFUNCION SEXUAL, HIPERTENSION, CIRROSIS HEPATICA, ENTRE OTROS
PE2011001019A 2008-11-28 2009-11-18 Arilciclohexileteres de dihidro-tetraazabenzoazuleno PE20110582A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08170188 2008-11-28

Publications (1)

Publication Number Publication Date
PE20110582A1 true PE20110582A1 (es) 2011-08-17

Family

ID=41382009

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011001019A PE20110582A1 (es) 2008-11-28 2009-11-18 Arilciclohexileteres de dihidro-tetraazabenzoazuleno

Country Status (32)

Country Link
US (2) US8227458B2 (es)
EP (1) EP2370441B1 (es)
JP (1) JP5452608B2 (es)
KR (1) KR101359742B1 (es)
CN (1) CN102227428B (es)
AR (2) AR074409A1 (es)
AU (1) AU2009319123B2 (es)
BR (1) BRPI0922303B1 (es)
CA (1) CA2743976C (es)
CO (1) CO6341478A2 (es)
CR (1) CR20110220A (es)
CY (1) CY1115435T1 (es)
DK (1) DK2370441T3 (es)
EC (1) ECSP11011089A (es)
ES (1) ES2431279T3 (es)
HK (1) HK1160642A1 (es)
HR (1) HRP20131067T1 (es)
IL (1) IL212122A (es)
MA (1) MA32781B1 (es)
MX (1) MX2011005596A (es)
MY (1) MY150837A (es)
NZ (1) NZ592076A (es)
PE (1) PE20110582A1 (es)
PL (1) PL2370441T3 (es)
PT (1) PT2370441E (es)
RU (1) RU2507205C2 (es)
SG (1) SG171846A1 (es)
SI (1) SI2370441T1 (es)
TW (1) TWI379833B (es)
UA (1) UA103504C2 (es)
WO (1) WO2010060836A1 (es)
ZA (1) ZA201103419B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011253058A1 (en) 2010-05-13 2012-12-06 Amgen Inc. Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
US8828989B2 (en) * 2011-09-26 2014-09-09 Hoffmann-La Roche Inc. Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists
CN103842365B (zh) * 2011-10-05 2017-06-23 霍夫曼-拉罗奇有限公司 作为V1a拮抗剂的环己基‑4H，6H‑5‑氧杂‑2，3，10b‑三氮杂‑苯并[e]薁
BR112016001948A2 (pt) * 2013-08-19 2017-08-01 Hoffmann La Roche antagonistas de v1a para tratar distúrbios do sono de desvio de fase
SG11201604502SA (en) 2013-12-05 2016-07-28 Hoffmann La Roche Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crytalline forms thereof
WO2017191117A1 (en) 2016-05-03 2017-11-09 Bayer Pharma Aktiengesellschaft V1a receptor antagonists for use in the treatment of renal diseases
RU2666598C1 (ru) * 2017-07-14 2018-09-11 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Средство для коррекции расстройств аутистического спектра
US11033601B2 (en) 2017-09-14 2021-06-15 The Regents Of The University Of Colorado, A Body Corporate Selective inhibition of V1b for treating fatty liver
AU2018379448A1 (en) 2017-12-08 2020-03-12 F. Hoffmann-La Roche Ag Pharmaceutical formulation
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
WO2020139670A1 (en) 2018-12-27 2020-07-02 Teva Pharmaceuticals International Gmbh Solid state forms of balovaptan

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521173A (en) 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
ATE249465T1 (de) * 1999-01-19 2003-09-15 Ortho Mcneil Pharm Inc Tricyclische benzodiazepine als vasopressin antagonisten
TWI239333B (en) * 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
GB0303852D0 (en) 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy
GB0400700D0 (en) * 2004-01-13 2004-02-18 Pfizer Ltd Compounds useful in therapy
KR100840852B1 (ko) 2004-05-25 2008-06-23 화이자 프로덕츠 인크. 테트라아자벤조[ｅ]아줄렌 유도체 및 이의 유사체
BRPI0510273A (pt) * 2004-05-25 2007-10-30 Pfizer Prod Inc derivados de tetraazabenzo[e]azuleno e análogos destes
EP1632494A1 (en) 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
EP1784408A1 (en) 2004-08-25 2007-05-16 Pfizer Limited Triazolobenzodiazepines and their use as vasopressin antagonists
US20080188478A1 (en) 2005-04-26 2008-08-07 Pfizer Inc. Compounds Useful In Therapy
WO2006123242A1 (en) 2005-05-18 2006-11-23 Pfizer Limited 1, 2, 4 -triazole derivatives as vasopressin antagonists
WO2008084005A1 (en) 2007-01-12 2008-07-17 F. Hoffmann-La Roche Ag Spiropiperidine glycinamide derivatives
AU2009234738B2 (en) * 2008-04-09 2012-01-19 Kuraray Co., Ltd. Gas barrier layered product and method for producing the same
AU2009315754B2 (en) 2008-11-13 2013-08-15 F. Hoffmann-La Roche Ag Spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes
JP5384659B2 (ja) 2008-11-18 2014-01-08 エフ．ホフマン−ラ ロシュ アーゲー ジヒドロテトラアザベンゾアズレンのアルキルシクロヘキシルエーテル
US8420633B2 (en) 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) * 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en) * 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes

Also Published As

Publication number Publication date
CN102227428B (zh) 2015-03-25
CA2743976C (en) 2017-02-21
US8227458B2 (en) 2012-07-24
CA2743976A1 (en) 2010-06-03
ES2431279T3 (es) 2013-11-25
IL212122A (en) 2013-06-27
RU2011123703A (ru) 2013-01-10
BRPI0922303B1 (pt) 2019-11-12
US8461152B2 (en) 2013-06-11
US20100137286A1 (en) 2010-06-03
MX2011005596A (es) 2011-06-16
NZ592076A (en) 2012-06-29
CO6341478A2 (es) 2011-11-21
DK2370441T3 (da) 2013-10-21
BRPI0922303A2 (pt) 2016-01-12
RU2507205C2 (ru) 2014-02-20
PT2370441E (pt) 2013-11-14
CY1115435T1 (el) 2017-01-04
AU2009319123B2 (en) 2014-10-23
HK1160642A1 (en) 2012-08-10
AR074409A1 (es) 2011-01-12
US20120225865A1 (en) 2012-09-06
KR20110077022A (ko) 2011-07-06
HRP20131067T1 (hr) 2013-12-06
EP2370441B1 (en) 2013-09-11
MY150837A (en) 2014-02-28
CN102227428A (zh) 2011-10-26
WO2010060836A1 (en) 2010-06-03
AU2009319123A1 (en) 2010-06-03
PL2370441T3 (pl) 2014-02-28
TWI379833B (en) 2012-12-21
CR20110220A (es) 2011-06-21
SG171846A1 (en) 2011-07-28
SI2370441T1 (sl) 2013-12-31
MA32781B1 (fr) 2011-11-01
JP5452608B2 (ja) 2014-03-26
AR112338A2 (es) 2019-10-16
EP2370441A1 (en) 2011-10-05
IL212122A0 (en) 2011-06-30
TW201024300A (en) 2010-07-01
KR101359742B1 (ko) 2014-02-06
ZA201103419B (en) 2014-07-30
ECSP11011089A (es) 2011-06-30
UA103504C2 (ru) 2013-10-25
JP2012510441A (ja) 2012-05-10

Similar Documents

Publication Publication Date Title
PE20110582A1 (es) Arilciclohexileteres de dihidro-tetraazabenzoazuleno
PE20090511A1 (es) Imidazopiridinonas
AR076749A1 (es) Pirrolo[2, 3 - b]piridinas como inhibidores de las protein quinasas raf
PE20130402A1 (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
EA201170771A1 (ru) Органические соединения
PE20170003A1 (es) Compuestos heterociclicos y usos de los mismos
CO6351786A2 (es) Inkibidores de la cinasa map p38
PE20090944A1 (es) PIRIMIDINAS BICICLICAS FUSIONADAS COMO INHIBIDORES DE LA VIA Pi3K/AKT
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
PE20091833A1 (es) Derivados heterociclicos espiro biciclicos o heterociclicos biciclicos, puenteados, de pirazolo [1,5-a]pirimidinas como inhibidores de quinasas raf y metodos para su preparacion
PE20080527A1 (es) Derivado de pirimidina como inhibidor de la fosfatidilinositol 3-quinasa (pi3k)
MX2009010728A (es) Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora.
PE20110122A1 (es) COMPUESTOS DERIVADOS DE 9H-PIRROLO[2,3-b:5,4-c]DIPIRIDIN-6-(PIRIDIN-3-IL) COMO INHIBIDORES DE LAS CINASA Pim
PE20140390A1 (es) Derivados de imidazo[1,2-b]piridazina e imidazo[4,5-b]piridina como inhibidores de jak
PE20120629A1 (es) Compuesto triazolopiridina y su accion como inhibidor de prolil hidroxilasa e inductor de la produccion de eritropoyetina
PE20090596A1 (es) Imidazoles biciclicos fusionados
EA200702074A1 (ru) Новые соединения
PE20090370A1 (es) Derivados de heterociclo fusionado como inhibidores de quinasa
PE20090210A1 (es) Compuestos derivados de pirazolo pirimidina como inhibidores de jak quinasa
CR20110230A (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
PE20120505A1 (es) Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a
PE20091306A1 (es) Pirrolopirimidinas y pirrolopiridinas
PE20120534A1 (es) PIRIMIDINAS FUSIONADAS COMO INHIBIDORES DE Akt
PE20160026A1 (es) Compuestos heterociclicos como agentes para control de plagas
PE20141855A1 (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos

Legal Events

Date Code Title Description
FG Grant, registration